Immune Response and Exhaled Breath Profile Changes after Initiation of CFTR Modulator Therapy in Children with CF
Background: In recent years, cystic fibrosis transmembrane regulator (CFTR) modulating therapy has made it possible to treat the underlying pathophysiological defect in children with cystic fibrosis (CF). Response to therapy varies among patients. We investigated the immune responses and exhaled bre...
Збережено в:
| Автори: | , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
MDPI AG
2024-08-01
|
| Серія: | International Journal of Translational Medicine |
| Предмети: | |
| Онлайн доступ: | https://www.mdpi.com/2673-8937/4/3/37 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|